Adenomyosis in the broad ligament and tamoxifen: Report of a case

Journal of Obstetrics and Gynaecology Research

Volumn 23, Issue 1, 1997, Pages 69-73

  Chung, Yi Pei ^a   Lin, Ho Hsiung ^a   Sheu, Bor Ching ^a   Mao, Tseuy Liang ^a   Chang, Daw Yuan ^a   Huang, Su Cheng ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Adenomyosis; Adnexal cyst; Broad ligament; Tamoxifen

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

ABDOMINAL HYSTERECTOMY; ADENOMYOSIS; ADULT; ARTICLE; BREAST CANCER; BROAD LIGAMENT; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LAPAROTOMY; SALPINGOOOPHORECTOMY; TRANSVAGINAL ECHOGRAPHY;

EID: 0030941558     PISSN: 13418076     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1447-0756.1997.tb00808.x     Document Type: Article

References (14)

1. Plowman PN. Tamoxifen as adjuvant therapy in breast cancer. Current status. Drugs 1993; 46: 819-833
2. Neven P, Shepherd JH, Lowe DG. Tamoxifen and the gynaecologist. Br J Obstet Gynaecol 1993; 100: 893-897
3. Gottardis MM, Robinson SP, Satyaswaroop PG, et al. Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse. Cancer Res 1988; 48: 812-815
4. Morgan MA, Gincherman Y, Mikuta JJ. Endometriosis and tamoxifen therapy. Int J Gyneacol Obstet 1994; 45: 55-57
5. Hajjar LR, Kim W, Nolan GH, et al. Intestinal and pelvic endometriosis presenting as a tumor and associated with tamoxifen therapy. Report of a case. Obstet Gynecol 1993; 82: 642-644
6. Cano A, Matallin P, Legua V, et al. Tamoxifen and uterus and endometrium (Letter). Lancet 1989; 1: 376
7. Fornander T, Cedermark B, Mattsson A, et al. Adjuvant tamoxifen in early breast cancer: Occurrence of new primary cancers. Lancet 1989; 1: 117-120
8. Neven P, Muylder XD, Belle YV, et al. Tamoxifen and the uterus and endometrium (Letter). Lancet 1989; 1: 375
9. Love RR. Tamoxifen in axillary node-negative breast cancer: Multisystem benefits and risks. Cancer Invest 1992; 10: 587-593
10. Jordan VC. A current view of tamoxifen for the treatment and prevention of breast cancer. Br J Pharmacol 1993; 10: 507-517
11. Cohen I, Rosen DJD, Shapira J, et al. Endometrial changes in postmenopausal women treated with tamoxifen for breast cancer. Br J Obstet Gynaecol 1993; 100: 567-570
12. Lahti E, Blanco G, Kauppila A, et al. Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Obstet Gynecol 1993; 81: 660-664
13. Zaloudek C, Nomis HJ. Mesenchymal tumors of the uterus. In: Kurman RJ, ed. Blaustein's pathology of the female genital tract. 3rd ed. New York: Springer-Verlag, 1987; 401-402
14. Jordan VC, Fritz NF, Fahey SL, et al. Alteration of endocrine parameters in premenopausal women with breast cancer during long-term adjuvant therapy with tamoxifen as the single agent. J Natl Cancer Inst 1991; 83: 1488-1491